News Corporation filed a current report on November 10, 2026, disclosing information provided to the Australian Securities Exchange regarding transactions under its stock repurchase program, with the earliest event reported as November 9, 2026.
Power Solutions International, Inc. filed an 8-K on November 10, 2026, disclosing a November 9, 2026 amendment to its long-standing supply agreement with HD Construction Equipment Co., Ltd. for GV22TI 22-liter natural gas engine long blocks covering calendar years 2027 and 2028.
Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (Pacific Airport Group) filed a Form 6-K with the SEC on November 10, 2026, reporting preliminary terminal passenger traffic figures for October 2026 across its airport network in Mexico and Jamaica.
TEN Holdings, Inc. filed a Form 8-K on November 10, 2026, disclosing that on November 9, 2026, it entered into a Stock Purchase Agreement to sell 3,389,831 shares of common stock in a registered direct offering at $0.59 per share, generating approximately $2.0 million …
Companhia Siderúrgica Nacional (National Steel Company) filed a Form 6-K with the U.S. Securities and Exchange Commission on November 10, 2026, disclosing a material change in its executive leadership effective November 9, 2026.
Duke Energy Corporation and seven of its subsidiaries filed an 8-K on November 10, 2026, disclosing that on November 9, 2026, they entered into Amendment No. 4 and Consent to their existing Amended and Restated Credit Agreement, obtaining lender consent for a planned internal …
Sixth Street Specialty Lending, Inc. filed a Form 8-K with the SEC on November 10, 2026, disclosing that it entered into equity distribution agreements on November 9, 2026 with five sales agents to offer and sell up to $100,000,000 of its common stock through …
Equinix, Inc. and its subsidiary Equinix Europe 2 Financing Corporation LLC filed a Form 8-A12B with the SEC on November 10, 2026, to register four series of senior notes on The Nasdaq Stock Market LLC.
WESCO International, Inc. filed a Form 8-K on November 10, 2026, disclosing a virtual investor event at which executive management presented the company's data center value proposition under the theme "Data Center Leadership: One Partner, Complete Lifecycle, Around the World."
Lipocine Inc. filed a Form 8-K on November 10, 2026, disclosing that the company dosed the first participant in its BLOOM Phase 3 Study of LPCN 1154 for postpartum depression.